Alnylam Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic …

Biotechnology
US, Cambridge [HQ]

Insiders

Transactions

Track non-derivative insider transactions.
i = Indirect d = Direct cs = Common Stock
Reported Owner(s) Position Now Transaction Date Type Position Change Extra
Statistics
Sample Size: 0 Transactions
Sale (S)
0
0.00%
Buy (P)
0
0.00%
100.00%
Other Ownership

Individuals

We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture: